SCHEMBL9770796

SCHEMBL9770796

CC(Cc1ccc(OCCO)cc1)N1CCOC(c2cccc(Cl)n2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
HRH3 Q9Y5N1 2/20 0.36
PPARG P37231 5/20 0.35
PPARA Q07869 2/20 0.35
DRD4 P21917 1/20 0.35
AVPR1B P47901 2/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
SIGMAR1 Q99720 2/20 0.33
CCNK O75909 1/20 0.33
CCND3 P30281 1/20 0.33
GSK3B P49841 1/20 0.33
CDK7 P50613 1/20 0.33
CDK9 P50750 1/20 0.33
CCNH P51946 1/20 0.33
CDK6 Q00534 1/20 0.33
CDK12 Q9NYV4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9770835 0.94 SLC2A1 (0.35) ADRB2ADRB1ADRB3HRH3PPARG
SCHEMBL9770964 0.89 SLC5A2 (0.35) HRH3PPARGPPARADRD4AVPR1B
SCHEMBL9770815 0.88 HRH3 (0.42) HRH3
SCHEMBL9770829 0.88 ADRB2 (0.38) ADRB2ADRB1ADRB3HRH3PPARG
SCHEMBL9770929 0.87 HTR1A (0.37) ADRB2ADRB1ADRB3HRH3PPARG
SCHEMBL9770863 0.87 ADRB2 (0.39) ADRB2ADRB1ADRB3HRH3PPARG
SCHEMBL9770885 0.86 HRH3 (0.35) HRH3PPARGPPARADRD4MEN1
SCHEMBL9770814 0.86 GLA (0.40) ADRB2ADRB1ADRB3HRH3DRD4
SCHEMBL8879419 0.85 HRH3 (0.36) ADRB2ADRB1ADRB3HRH3PPARG
SCHEMBL9770894 0.85 AVPR1B (0.38) ADRB2ADRB1ADRB3HRH3AVPR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026702-A Enhances physical performance in animals, effective in lowering blood sugar, reducing body fat and lowering atherogenic lipoproteins DR. KARL THOMAE, GMBH (DE) 1991-06-25 US claimed
EP-0334146-A1 Morpholines and morpholine-N-oxides, medicines containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1989-09-27 EP claimed
US-5026702-A Enhances physical performance in animals, effective in lowering blood sugar, reducing body fat and lowering atherogenic lipoproteins DR. KARL THOMAE, GMBH (DE) 1991-06-25 US disclosed
EP-0334146-A1 Morpholines and morpholine-N-oxides, medicines containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1989-09-27 EP disclosed